Patents

Vaxiion Therapeutics, Inc. Granted Broad Patent Protection for Breakthrough Vaccine Delivery System

Published in TB and Outbreaks Week, March 13th, 2007

Vaxiion Therapeutics, Inc. announced the issuance of U.S. patent no. 7,183,105 from the U.S. Patent and Trademark Office. The patent is entitled, "Eubacterial minicells and their use as vectors for nucleic acid delivery and expression," and broadly relates to compositions and methods of using Vaxiion's proprietary minicells as vaccine delivery vehicles.

"This broad patent helps to secure Vaxiion's proprietary position with regard to minicells as vaccines," said Dr. Roger A. Sabbadini, the founder and president, and a listed inventor in the patent. "This also represents a major milestone in our efforts to develop this powerful DNA and protein delivery system for the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2007-03-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry